E M Bordewijk
Publication Activity (10 Years)
Years Active: 2019-2024
Publications (10 Years): 8
Publications (10 Years): 8
Publications
- T I Jannink, E M Bordewijk, J Aalberts, J Hendriks, Vicky Lehmann, Annemieke Hoek, Mariëtte Goddijn, Madelon van Wely, null null
- T I Jannink, E M Bordewijk, J Aalberts, J Hendriks, Vicky Lehmann, Annemieke Hoek, Mariëtte Goddijn, Madelon van Wely, null null
- T I Jannink, E M Bordewijk, J Aalberts, J Hendriks, Vicky Lehmann, Annemieke Hoek, Mariëtte Goddijn, Madelon van Wely, null null
- T I Jannink, E M Bordewijk, J Aalberts, J Hendriks, Vicky Lehmann, Annemieke Hoek, Mariëtte Goddijn, Madelon van Wely, null null
- E M Bordewijk, T I Jannink, N S Weiss, T de Vries, M Nahuis, A Hoek, M Goddijn, B W Mol, Madelon van Wely, null nullLong-term outcomes of switching to gonadotrophins versus continuing with clomiphene citrate, with or without intrauterine insemination, in women with normogonadotropic anovulation and clomiphene failure: follow-up study of a factorial randomized clinical trial. Human reproduction (Oxford, England) 38 (3) (2023)
- E M Bordewijk, T I Jannink, N S Weiss, T de Vries, M Nahuis, A Hoek, M Goddijn, B W Mol, Madelon van Wely, null nullLong-term outcomes of switching to gonadotrophins versus continuing with clomiphene citrate, with or without intrauterine insemination, in women with normogonadotropic anovulation and clomiphene failure: follow-up study of a factorial randomized clinical trial. Human reproduction (Oxford, England) 38 (3) (2023)
- E M Bordewijk, T I Jannink, N S Weiss, T de Vries, M Nahuis, A Hoek, M Goddijn, B W Mol, Madelon van Wely, null nullLong-term outcomes of switching to gonadotrophins versus continuing with clomiphene citrate, with or without intrauterine insemination, in women with normogonadotropic anovulation and clomiphene failure: follow-up study of a factorial randomized clinical trial. Human reproduction (Oxford, England) (2023)
- E M Bordewijk, F Mol, F van der Veen, Madelon van Wely